167 related articles for article (PubMed ID: 37902879)
21. Brain Proteome-Wide and Transcriptome-Wide Asso-ciation Studies, Bayesian Colocalization, and Mendelian Randomization Analyses Reveal Causal Genes of Parkinson's Disease.
Zhou S; Tian Y; Song X; Xiong J; Cheng G
J Gerontol A Biol Sci Med Sci; 2023 Mar; 78(4):563-568. PubMed ID: 36511626
[TBL] [Abstract][Full Text] [Related]
22. Sleep behaviors and Parkinson's disease: A bidirectional Mendelian randomization analysis.
Ling Y; Zhu J; Yan F; Tse LA; Kinra S; Jiang M
Behav Brain Res; 2023 Mar; 441():114281. PubMed ID: 36608706
[TBL] [Abstract][Full Text] [Related]
23. Neuroticism, Smoking, and the Risk of Parkinson's Disease.
Sieurin J; Zhan Y; Pedersen NL; Wirdefeldt K
J Parkinsons Dis; 2021; 11(3):1325-1334. PubMed ID: 34024779
[TBL] [Abstract][Full Text] [Related]
24. Effect of plasma vitamin C levels on Parkinson's disease and age at onset: a Mendelian randomization study.
Liu H; Zhang Y; Zhang H; Wang L; Wang T; Han Z; Wu L; Liu G
J Transl Med; 2021 May; 19(1):221. PubMed ID: 34030714
[TBL] [Abstract][Full Text] [Related]
25. Genome-Wide Association Studies of Cognitive and Motor Progression in Parkinson's Disease.
Tan MMX; Lawton MA; Jabbari E; Reynolds RH; Iwaki H; Blauwendraat C; Kanavou S; Pollard MI; Hubbard L; Malek N; Grosset KA; Marrinan SL; Bajaj N; Barker RA; Burn DJ; Bresner C; Foltynie T; Wood NW; Williams-Gray CH; Hardy J; Nalls MA; Singleton AB; Williams NM; Ben-Shlomo Y; Hu MTM; Grosset DG; Shoai M; Morris HR
Mov Disord; 2021 Feb; 36(2):424-433. PubMed ID: 33111402
[TBL] [Abstract][Full Text] [Related]
26. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Nalls MA; Blauwendraat C; Vallerga CL; Heilbron K; Bandres-Ciga S; Chang D; Tan M; Kia DA; Noyce AJ; Xue A; Bras J; Young E; von Coelln R; Simón-Sánchez J; Schulte C; Sharma M; Krohn L; Pihlstrøm L; Siitonen A; Iwaki H; Leonard H; Faghri F; Gibbs JR; Hernandez DG; Scholz SW; Botia JA; Martinez M; Corvol JC; Lesage S; Jankovic J; Shulman LM; Sutherland M; Tienari P; Majamaa K; Toft M; Andreassen OA; Bangale T; Brice A; Yang J; Gan-Or Z; Gasser T; Heutink P; Shulman JM; Wood NW; Hinds DA; Hardy JA; Morris HR; Gratten J; Visscher PM; Graham RR; Singleton AB; ; ;
Lancet Neurol; 2019 Dec; 18(12):1091-1102. PubMed ID: 31701892
[TBL] [Abstract][Full Text] [Related]
27. Mendelian Randomization Analysis Reveals No Causal Relationship Between Plasma α-Synuclein and Parkinson's Disease.
Zhang Q; Lin Z; He Y; Jiang J; Hu D
Mol Neurobiol; 2023 Apr; 60(4):2268-2276. PubMed ID: 36640248
[TBL] [Abstract][Full Text] [Related]
28. Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression.
Reyes-Pérez P; García-Marín LM; Aman AM; Antar T; Flores-Ocampo V; Mitchell BL; Medina-Rivera A; Rentería ME
J Parkinsons Dis; 2024; 14(3):483-493. PubMed ID: 38457145
[TBL] [Abstract][Full Text] [Related]
29. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR
Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982
[TBL] [Abstract][Full Text] [Related]
30. Lack of Causal Associations of Inflammatory Bowel Disease with Parkinson's Disease and Other Neurodegenerative Disorders.
Zeng R; Wang J; Zheng C; Jiang R; Tong S; Wu H; Zhuo Z; Yang Q; Leung FW; Sha W; Chen H
Mov Disord; 2023 Jun; 38(6):1082-1088. PubMed ID: 36959736
[TBL] [Abstract][Full Text] [Related]
31. Peripheral immune cell traits and Parkinson's disease: A Mendelian randomization study.
Tian J; Zuo C; Shi J; Ma D; Shi C
PLoS One; 2024; 19(3):e0299026. PubMed ID: 38442099
[TBL] [Abstract][Full Text] [Related]
32. Investigating the causality of metabolites involved in one-carbon metabolism with the risk and age at onset of Parkinson's disease: A two-sample mendelian randomization study.
Zhao Y; Tian D; Guo N; Zhang C; Zhu R; Liu X; Zhang J
Neurobiol Aging; 2021 Dec; 108():196-199. PubMed ID: 34325950
[TBL] [Abstract][Full Text] [Related]
33. GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.
Senkevich K; Zorca CE; Dworkind A; Rudakou U; Somerville E; Yu E; Ermolaev A; Nikanorova D; Ahmad J; Ruskey JA; Asayesh F; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Grenn FP; Chiang MSR; Sardi SP; Vanderperre B; Blauwendraat C; Trempe JF; Fon EA; Durcan TM; Alcalay RN; Gan-Or Z
Brain; 2023 May; 146(5):1859-1872. PubMed ID: 36370000
[TBL] [Abstract][Full Text] [Related]
34. Exploring the causal relationship between B lymphocytes and Parkinson's disease: a bidirectional, two-sample Mendelian randomization study.
Song J; Qin Y; Wang L; Quan W; Xu J; Li J; Chen J
Sci Rep; 2024 Feb; 14(1):2783. PubMed ID: 38307922
[TBL] [Abstract][Full Text] [Related]
35. The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease.
Bandres-Ciga S; Saez-Atienzar S; Bonet-Ponce L; Billingsley K; Vitale D; Blauwendraat C; Gibbs JR; Pihlstrøm L; Gan-Or Z; ; Cookson MR; Nalls MA; Singleton AB
Mov Disord; 2019 Apr; 34(4):460-468. PubMed ID: 30675927
[TBL] [Abstract][Full Text] [Related]
36. Psoriasis and progression of Parkinson's disease: a Mendelian randomization study.
Li C; Li X; Lin J; Cui Y; Shang H
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2401-2405. PubMed ID: 35870136
[TBL] [Abstract][Full Text] [Related]
37. Mendelian randomization study shows no causal relationship between circulating urate levels and Parkinson's disease.
Kia DA; Noyce AJ; White J; Speed D; Nicolas A; ; Burgess S; Lawlor DA; Davey Smith G; Singleton A; Nalls MA; Sofat R; Wood NW
Ann Neurol; 2018 Aug; 84(2):191-199. PubMed ID: 30014513
[TBL] [Abstract][Full Text] [Related]
38. Functional genomics elucidates regulatory mechanisms of Parkinson's disease-associated variants.
Chen R; Liu J; Li S; Li X; Huo Y; Yao YG; Xiao X; Li M; Luo XJ
BMC Med; 2022 Feb; 20(1):68. PubMed ID: 35168626
[TBL] [Abstract][Full Text] [Related]
39. Differential Analysis of A-to-I mRNA Edited Sites in Parkinson's Disease.
Pozdyshev DV; Zharikova AA; Medvedeva MV; Muronetz VI
Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052353
[TBL] [Abstract][Full Text] [Related]
40. Causal role of myeloid cells in Parkinson's disease: Mendelian randomization study.
Quan W; Qin Y; Li J; Wang L; Song J; Xu J; Chen J
Inflamm Res; 2024 May; 73(5):809-818. PubMed ID: 38538756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
